AQR Arbitrage’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

AQR Arbitrage’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,499	Closed	-$1.69K	–	1247
2022 Q4	$1.69K	Hold	26,499	–	–	﹤0.01%	1140
2022 Q3	$2K	Hold	26,499	–	–	﹤0.01%	1376
2022 Q2	$2K	Hold	26,499	–	–	﹤0.01%	1473
2022 Q1	$6K	Hold	26,499	–	–	﹤0.01%	1318
2021 Q4	$261K	Hold	26,499	–	–	0.01%	1061
2021 Q3	$17K	Hold	26,499	–	–	﹤0.01%	1102
2021 Q2	$23K	Buy	+26,499	New	+$18.4K	﹤0.01%	1055

AQR Arbitrage's BIOTW Position: Q1 2023 in Review

AQR Arbitrage sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 26,499 shares — an estimated $1.69K sold.

AQR Arbitrage first reported a position in BIOTW in Q2 2021 and held it in 7 quarters. The position peaked at $261K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

AQR Arbitrage reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
AQR Arbitrage sold 26,499 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $1.69K.
AQR Arbitrage first reported a position in Biotech Acquisition Company Warrant in Q2 2021 and held it in 7 quarters.
AQR Arbitrage's Biotech Acquisition Company Warrant position peaked at $261K in Q4 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.